Clinical Trial Update: Eltrombopag for People With Fanconi Anemia [Phase 2]

View source ↗

Summary

A phase 2 clinical trial of eltrombopag for people with Fanconi anemia is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fanconi Anemia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Fanconi Anemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING